17 Oct 2024    Quarterly Activities Report and Appendix 4C  
 
17 Oct 2024    Cleansing Notice  
 
17 Oct 2024    Application for quotation of securities - LGP  
 
06 Sep 2024    Change of Director's Interest Notice x 2  
 
03 Sep 2024    Notification regarding unquoted securities - LGP  
 
29 Aug 2024    Results of Annual General Meeting  
 
08 Aug 2024    Addendum to Notice of Annual General Meeting  
 
25 Jul 2024    Investor Presentation  
 
24 Jul 2024    Letter to Shareholders regarding Annual General Meeting  
 
24 Jul 2024    Notice of Annual General Meeting  
 
24 Jul 2024    Change of Registered Office and Principal Place of Business  
 
22 Jul 2024    Quarterly Activities Report and Appendix 4C  
 
22 Jul 2024    Change in FY2024 AGM date  
 
22 Jul 2024    Notification of cessation of securities - LGP  
 
10 Jul 2024    Change in BDO Auditor entity  
 
31 May 2024    Corporate Governance Statement and Appendix 4G  

Corporate Governance Statement and Appendix 4G 

 		 
31 May 2024    Appendix 4E and 2024 Annual Report  

Little Green Pharma Ltd is pleased to share its 2024 Annual Report to Shareholders. 

 		 
02 May 2024    US Reschedules Cannabis  
 
29 Apr 2024    Investor Webinar & Presentation March 2024 Quarterly Reports  
 
17 Apr 2024    Quarterly Activities Report & Appendix 4C  
 
16 Apr 2024    Change of Director's Interest Notice x 2  
 
16 Apr 2024    Application for quotation of securities - LGP  
 
16 Apr 2024    Application for quotation of securities - LGP  
 
16 Apr 2024    Notification regarding unquoted securities - LGP  
 
16 Apr 2024    Notification of cessation of securities - LGP  
 
03 Apr 2024    Application for quotation of securities - LGP  
 
28 Feb 2024    First Polish Shipment  
 
26 Feb 2024    Germany Legalises Cannabis  
 
21 Feb 2024    Results of General Meeting and appointment of auditor  
 
19 Feb 2024    Final Appendix 3A.5  
 
19 Feb 2024    Reset Offers withdrawn and Reset to remain LGP subsidiary  
 
08 Feb 2024    Investor Webinar & December Quarterly Results Presentation  
 
01 Feb 2024    LGP receives $5 million R&D rebate  
 
31 Jan 2024    Quarterly Activities Report & Appendix 4C  
 
17 Jan 2024    Updated Appendix 3A.5  
 
17 Jan 2024    Extension of Reset Offers and change of General Meeting date  
 
11 Jan 2024    Reset sponsored WA Psilocybin Clinical Trial Opens  
 
04 Jan 2024    Updated Appendix 3A.5  
 
04 Jan 2024    Reset Offers extension and change of General Meeting date  
 
12 Dec 2023    Updated Appendix 3A.5  
 
11 Dec 2023    Change of date of General Meeting and Reset Offers  
 
07 Dec 2023    LGP to capitalise on new French cannabis healthcare laws  
 
30 Nov 2023    CEO Update on Financial Results  
 
30 Nov 2023    Half Yearly Financial Presentation  
 
30 Nov 2023    Half Yearly Report and Accounts  
 
21 Nov 2023    Reset Mind Sciences Investor Webinar  
 
20 Nov 2023    Reset Mind Sciences - Investor Presentation  
 
17 Nov 2023    Reset Mind Sciences Offers Open  
 
10 Nov 2023    Letter to Shareholders regarding Demerger & Priority Offer  
 
10 Nov 2023    Long Form Prospectus  
 
10 Nov 2023    Short Form Prospectus  
 
10 Nov 2023    Letter to Shareholders regarding Notice of General Meeting  
 
10 Nov 2023    Notice of General Meeting  
 
10 Nov 2023    Appendix 3A.5  
 
10 Nov 2023    Correction of Defective Cleansing Notice  
 
31 Oct 2023    Quarterly Activities Report & Appendix 4C  
 
04 Oct 2023    Change of Director's Interest Notice x 5  
 
27 Sep 2023    Cleansing notice  
 
27 Sep 2023    Application for quotation of securities - LGP  
 
27 Sep 2023    Notification regarding unquoted securities - LGP  
 
27 Sep 2023    Application for quotation of securities - LGP  
 
27 Sep 2023    Application for quotation of securities - LGP  
 
18 Sep 2023    Change of registry address notification  
 
07 Sep 2023    Large scale cannabis study findings released  
 
30 Aug 2023    Annual General Meeting Results Additional Information  
 
29 Aug 2023    Results of Meeting  
 
29 Aug 2023    AGM Presentation and Company Update  
 
16 Aug 2023    Change in Leadership at Little Green Pharma  
 
02 Aug 2023    Desert Flame granted Polish Marketing Authorisation  
 
01 Aug 2023    Notification of cessation of securities - LGP  
 
01 Aug 2023    Application for quotation of securities - LGP  
 
01 Aug 2023    Change in substantial holding  
 
01 Aug 2023    Change in substantial holding  
 
31 Jul 2023    Letter to Shareholders regarding Annual General Meeting  
 
28 Jul 2023    Notice of Annual General Meeting  
 
28 Jul 2023    Quarterly Activities Report & Appendix 4C  
 
14 Jul 2023    Change of Director's Interest Notice x 3  
 
14 Jul 2023    Application for quotation of securities - LGP  
 
12 Jul 2023    LGP Awarded French trial tender for CBD50  
 
07 Jul 2023    Notification of cessation of securities - LGP  
 
07 Jul 2023    Application for quotation of securities - LGP  
 
07 Jul 2023    Application for quotation of securities - LGP  
 
07 Jul 2023    AGM date and closing date for director nominations  
 
03 Jul 2023    Reset Mind Sciences signs long-term property lease  
 
30 Jun 2023    Annual Report to shareholders  
 
30 Jun 2023    Corporate Governance Statement and Appendix 4G  
 
31 May 2023    Preliminary Final Report  
 
08 May 2023    LGP wins extended French government tender  
 
01 May 2023    Change of Director's Interest Notice x 4  
 
27 Apr 2023    Quarterly Activities Report & Appendix 4C  
 
24 Apr 2023    Application for quotation of securities - LGP  
 
24 Apr 2023    Application for quotation of securities - LGP  
 
24 Apr 2023    Notification regarding unquoted securities - LGP  
 
24 Apr 2023    Notification of cessation of securities - LGP  
 
17 Apr 2023    First shipment to Ilios Sante in Germany  
 
31 Mar 2023    Change in substantial holding - Tiga Trading Pty Ltd  
 
31 Mar 2023    Cleansing notice  
 
31 Mar 2023    Application for quotation of securities - LGP  
 
24 Mar 2023    Proposed issue of securities - LGP  
 
24 Mar 2023    Proposed issue of securities - LGP  
 
24 Mar 2023    Successful completion of $5 million placement  
 
22 Mar 2023    Trading Halt  
 
22 Mar 2023    Reset Mind Sciences and HIF enter Strategic Alliance  
 
15 Mar 2023    Change in substantial holding - Tiga Trading Pty Ltd  
 
06 Mar 2023    Change of Director's Interest Notice x 4  
 
27 Feb 2023    Cleansing notice  
 
27 Feb 2023    Notification regarding unquoted securities - LGP  
 
27 Feb 2023    Application for quotation of securities - LGP  
 
27 Feb 2023    Notification regarding unquoted securities - LGP  
 
27 Feb 2023    Application for quotation of securities - LGP  
 
15 Feb 2023    Ethics approval granted for psilocybin clinical trial  
 
08 Feb 2023    Ceasing to be a substantial holder  
 
06 Feb 2023    Psilocybin and MDMA down-scheduled  
 
02 Feb 2023    Amended Constitution  
 
31 Jan 2023    Results of Meeting  
 
19 Jan 2023    Notification regarding unquoted securities - LGP  
 
19 Jan 2023    Results of Share Purchase Plan  
 
19 Jan 2023    Application for quotation of securities - LGP  
 
16 Jan 2023    Quarterly Activities Report & Appendix 4C  
 
13 Jan 2023    Notification of cessation of securities - LGP  
 
30 Dec 2022    Change in substantial holding  
 
29 Dec 2022    Letter to Shareholders regarding General Meeting  
 
29 Dec 2022    Notice of General Meeting  
 
19 Dec 2022    Share Purchase Plan offer extended to 16 January 2023  
 
14 Dec 2022    Corrected Appendix 3B  
 
14 Dec 2022    Correction to Announcement and Appendix 3B  
 
02 Dec 2022    Second exclusive supply agreement with Cannamedical  
 
30 Nov 2022    Ethics approval for CBD Phase III clinical trial  
 
30 Nov 2022    Half Yearly Report and Accounts  
 
25 Nov 2022    LGP wins National Export Award for International Health  
 
24 Nov 2022    LGP significantly expands flower portfolio  
 
22 Nov 2022    Change in substantial holding  
 
21 Nov 2022    Letter to Shareholders for Share Purchase Plan  
 
21 Nov 2022    Prospectus  
 
21 Nov 2022    Share Purchase Plan open to eligible shareholders  
 
21 Nov 2022    Update Four 20 Pharma and French trial extension  
 
10 Nov 2022    Change in substantial holding  
 
09 Nov 2022    Cleansing Notice  
 
09 Nov 2022    Application for quotation of securities - LGP  
 
09 Nov 2022    Correction to Appendix 3Y  
 
02 Nov 2022    Proposed issue of securities - LGP  
 
02 Nov 2022    Proposed issue of securities - LGP  
 
02 Nov 2022    LGP announces $4 million placement and $2 million SPP  
 
31 Oct 2022    Quarterly Activities Report & Appendix 4C  
 
31 Oct 2022    Trading Halt  
 
25 Oct 2022    Notice of change in auditor  
 
06 Oct 2022    Notification of cessation of securities - LGP  
 
06 Oct 2022    Change in substantial holding  
 
04 Oct 2022    Exclusive supply agreement with Cannamedical in Germany  
 
28 Sep 2022    TGA advertising infringement notices  
 
06 Sep 2022    Amended Constitution  
 
06 Sep 2022    Change of Director's Interest Notice x 4  
 
06 Sep 2022    Notification regarding unquoted securities - LGP  
 
06 Sep 2022    Application for quotation of securities - LGP  
 
30 Aug 2022    Results of Meeting  
 
29 Aug 2022    AGM Company Update  
 
17 Aug 2022    Notice of Release from Escrow  
 
02 Aug 2022    Notification of cessation of securities - LGP  
 
29 Jul 2022    Letter to Shareholders regarding Annual General Meeting  
 
29 Jul 2022    Notice of Annual General Meeting  
 
27 Jul 2022    Quarterly Activities Report & Appendix 4C  
 
21 Jul 2022    Change of Director's Interest Notice  
 
20 Jul 2022    Notification regarding unquoted securities - LGP  
 
20 Jul 2022    Application for quotation of securities - LGP  
 
20 Jul 2022    Notification of cessation of securities - LGP  
 
20 Jul 2022    Application for quotation of securities - LGP  
 
15 Jul 2022    AGM Date and Closing Date for Director Nominations  
 
13 Jul 2022    Change in substantial holding  
 
12 Jul 2022    LGP signs $2M supply agreement with Ilios Sante  
 
07 Jul 2022    Initial Director's Interest Notice  
 
07 Jul 2022    Former Bayer Regulatory & Quality Director joins LGP Board  
 
01 Jul 2022    Corporate Governance Statement and Appendix 4G  
 
01 Jul 2022    Annual Report to shareholders  
 
06 Jun 2022    Company Update Presentation  
 
31 May 2022    Preliminary Final Report  
 
19 May 2022    Exclusive supply contract for new high-THC strain in Germany  
 
09 May 2022    Cleansing Notice  
 
09 May 2022    Application for quotation of securities - LGP  
 
02 May 2022    LGP Signs Key UK Supply Agreement  
 
29 Apr 2022    Quarterly Activities Report & Appendix 4C  
 
19 Apr 2022    LGP Denmark Signs Major Sales Agreement with Demecan  
 
14 Mar 2022    Change of Director's Interest Notice  
 
07 Mar 2022    Cleansing Notice  
 
07 Mar 2022    Application for quotation of securities - LGP  
 
28 Feb 2022    Half Yearly Report and Accounts  
 
18 Feb 2022    Application for quotation of securities - LGP  
 
18 Feb 2022    LGP Wins Italian Tender  
 
10 Feb 2022    Notice of Release from Escrow  
 
08 Feb 2022    Intention to Demerge Psychedelics Business  
 
02 Feb 2022    Company Update Presentation  
 
27 Jan 2022    Quarterly Activities Report & Appendix 4C  
 
21 Jan 2022    Exclusive Distribution Agreement for LGP Medicines in Greece  
 
19 Jan 2022    Exclusive Cannabis Oils Distribution Agreement in Germany  
 
07 Dec 2021    Application for quotation of securities - LGP  
 
01 Dec 2021    Change in substantial holding  
 
01 Dec 2021    Change in substantial holding  
 
23 Nov 2021    First Registration for Produced Cannabis Medicine in Denmark  
 
22 Nov 2021    Results of Meeting  
 
29 Oct 2021    Jobkeeper Payments FY2021 & FY2020  
 
27 Oct 2021    Investor Presentation  
 
27 Oct 2021    Investor Presentation  
 
27 Oct 2021    Quarterly Activities Report & Appendix 4C  
 
27 Oct 2021    Quarterly Activities Report & Appendix 4C  
 
25 Oct 2021    Presentation at South-West Connect ASX Showcase  
 
15 Oct 2021    Letter to Shareholders regarding Annual General Meeting  
 
15 Oct 2021    Notice of Annual General Meeting  
 
29 Sep 2021    Annual Report to shareholders  
 
29 Sep 2021    Appendix 4G and Corporate Governance Statement  
 
08 Sep 2021    Change of Director's Interest Notice x 2  
 
07 Sep 2021    LGP expands into Psychedelic Medicines  
 
06 Sep 2021    First Danish Shipment to Australia, Key Appointments  
 
06 Sep 2021    AGM Date and Closing Date for Director Nominations  
 
06 Sep 2021    Notification regarding unquoted securities - LGP  
 
31 Aug 2021    Preliminary Final Report  
 
31 Aug 2021    Preliminary Final Report  
 
18 Aug 2021    Change of Director's Interest Notice x 2  
 
17 Aug 2021    Cleansing Notice  
 
17 Aug 2021    Application for quotation of securities - LGP  
 
17 Aug 2021    Notification regarding unquoted securities - LGP  
 
17 Aug 2021    Application for quotation of securities - LGP  
 
17 Aug 2021    Notification regarding unquoted securities - LGP  
 
28 Jul 2021    Quarterly Activities Report & Appendix 4C  
 
19 Jul 2021    Results of Meeting  
 
07 Jul 2021    Change in substantial holding  
 
06 Jul 2021    Becoming a substantial holder  
 
06 Jul 2021    Investor Webinar - Denmark Acquisition  
 
05 Jul 2021    Change in substantial holding  
 
02 Jul 2021    Change in substantial holding - Tiga Trading Pty Ltd  
 
01 Jul 2021    Becoming a substantial holder  
 
01 Jul 2021    Cleansing Notice  
 
01 Jul 2021    Investor Presentation  
 
30 Jun 2021    Application for quotation of securities - LGP  
 
22 Jun 2021    Proposed issue of securities - LGP  
 
22 Jun 2021    Investor Presentation - Denmark acquisition & capital raise  
 
22 Jun 2021    LGP acquires Denmark facility and undertakes share placement  
 
21 Jun 2021    Trading Halt  
 
17 Jun 2021    Exclusive distribution partner - leading Polish pharma group  
 
17 Jun 2021    Letter to Shareholders regarding General Meeting  
 
17 Jun 2021    Notice of General Meeting  
 
15 Jun 2021    Update to Sales and Distribution in Australia and Germany  
 
10 Jun 2021    Becoming a substantial holder - Tiga Trading Pty Ltd  
 
28 May 2021    Results of Meeting  
 
27 May 2021    $2.5m firm order increases expected DEMECAN revenue to $5.7m  
 
28 Apr 2021    Quarterly Activities Report & Appendix 4C  
 
27 Apr 2021    Letter to Shareholders regarding General Meeting  
 
27 Apr 2021    Notice of Extraordinary General Meeting  
 
20 Apr 2021    LGP agrees Danish Distribution Agreement with Balancial  
 
23 Mar 2021    Ceasing to be a substantial holder  
 
15 Mar 2021    Proposed issue of Securities - LGP  
 
15 Mar 2021    Firm purchase order from Demecan and acquisition of land  
 
12 Mar 2021    Change of Director's Interest Notice x 4  
 
12 Mar 2021    Appendix 3G - employee share rights  
 
12 Mar 2021    Cleansing Notice  
 
12 Mar 2021    Appendix 2A - incentive shares & conversion of share rights  
 
12 Mar 2021    Appendix 2A - shares for services  
 
12 Mar 2021    Appendix 2A - conversion of Performance Rights  
 
12 Mar 2021    Appendix 2A - Share Purchase Plan shares  
 
11 Mar 2021    LGP delivers first French shipment  
 
08 Mar 2021    LGP Completes Successful $5 Million SPP  
 
08 Mar 2021    LGP Completes Successful $5 Million SPP  
 
01 Mar 2021    Change in substantial holding  
 
01 Mar 2021    Change in substantial holding  
 
24 Feb 2021    Company Update and Presentation of Half Yearly Results  
 
24 Feb 2021    Half Yearly Report and Accounts  
 
24 Feb 2021    Half Yearly Report and Accounts  
 
18 Feb 2021    Large Scale Cannabis Study Launched  
 
18 Feb 2021    Large Scale Cannabis Study Launched  
 
15 Feb 2021    Appendix 2A - issue of placement shares & cleansing notice  
 
15 Feb 2021    Share Purchase Plan Offer Booklet  
 
09 Feb 2021    Cleansing Notice  
 
09 Feb 2021    Proposed issue of Securities - LGP  
 
09 Feb 2021    LGP secures firm commitments to raise $22 million  
 
08 Feb 2021    Appendix 2A  
 
08 Feb 2021    Appendix 2A - exercise of options  
 
05 Feb 2021    Appendix 2A - release of shares from escrow  
 
05 Feb 2021    LGP exports first commercial shipment to Germany  
 
05 Feb 2021    Trading Halt  
 
29 Jan 2021    Quarterly Activities Report & Appendix 4C  
 
28 Jan 2021    Notice of release from escrow  
 
27 Jan 2021    LGP wins French government tender  
 
12 Jan 2021    Appendix 2A - options exercise & cleansing notice  
 
17 Dec 2020    Change of Director's interest notice x 4  
 
17 Dec 2020    Appendix 2A - options exercise & cleansing notice  
 
17 Dec 2020    Appendix 2A  
 
17 Dec 2020    Appendix 3G  
 
17 Dec 2020    Issue of securities approved at AGM  
 
16 Dec 2020    TGA announces final CBD down-scheduling decision  
 
26 Nov 2020    Results of Annual General Meeting  
 
26 Nov 2020    Company Update to the AGM  
 
19 Nov 2020    First Australian Medicinal Cannabis Oils Exported to Germany  
 
10 Nov 2020    Proposed issue of Securities - LGP  
 
10 Nov 2020    LGP enters strategic partnership with HIF  
 
10 Nov 2020    Trading Halt  
 
10 Nov 2020    Proposed issue of Securities - LGP  
 
27 Oct 2020    Letter to Shareholders regarding Annual General Meeting  
 
27 Oct 2020    Notice of Annual General Meeting  
 
26 Oct 2020    Appendix 2A - Exercise of Options and Cleansing Notice  
 
26 Oct 2020    Quarterly Activities Report & Appendix 4C  
 
21 Oct 2020    Becoming a substantial holder- Tiga Trading Pty Ltd  
 
14 Oct 2020    Little Green Pharma granted GMP Licence  
 
07 Oct 2020    Appendix 2A - Release from Escrow  
 
02 Oct 2020    AGM Date and Closing Date for Director Nominations  
 
30 Sep 2020    Notice of release from escrow  
 
22 Sep 2020    TGA Medicinal Cannabis Post Market Survey  
 
10 Sep 2020    LGP welcomes proposed CBD down-scheduling  
 
04 Sep 2020    Change in substantial holding  
 
31 Aug 2020    Appendix 4G  
 
31 Aug 2020    2020_Annual Report to shareholders  
 
28 Aug 2020    Appendix 2A and Cleansing Notice  
 
28 Aug 2020    Proposed issue of Securities - LGP  
 
26 Aug 2020    Appendix 2A and Cleansing Notice  
 
14 Aug 2020    Appendix 2A - Exercise of Options and Cleansing Notice  
 
03 Aug 2020    Appendix 2A - Release from Escrow  
 
24 Jul 2020    Change in substantial holding  
 
24 Jul 2020    Notice of Release from Escrow  
 
23 Jul 2020    Investor Update Webinar  
 
22 Jul 2020    Investor Presentation  
 
22 Jul 2020    July 2020_Quarterly Activities Report and Appendix 4C  
 
20 Jul 2020    Medicinal Cannabis Permit Granted for Expanded Facility  
 
01 Jul 2020    Appendix 2A - Exercise of Options and Cleansing Notice  
 
01 Jul 2020    Appendix 2A - Release from Escrow  
 
01 Jul 2020    Notice of Release from Escrow  
 
01 Jul 2020    Change of Company Secretary  
 
29 Jun 2020    Strategic Shipment Exported to the UK  
 
28 May 2020    Sales Update - April 2020  
 
13 May 2020    Clarification Statement  
 
11 May 2020    ODC Manufacturing Permit Granted  
 
08 May 2020    Proposed issue of Securities - LGP  
 
30 Apr 2020    Investor Presentation  
 
30 Apr 2020    March 2020_Quarterly Activities Report and Appendix 4C  
 
30 Apr 2020    Virtual Conference  
 
15 Apr 2020    First UK Shipment of Australian Medicinal Cannabis Oil  
 
02 Apr 2020    COVID-19 Business Update  
 
26 Mar 2020    Commissioning of Cultivation Facility Expansion Complete  
 
16 Mar 2020    Investor Presentation  
 
12 Mar 2020    Expanded Medicinal Licence and new Manufacturing Licence  
 
02 Mar 2020    Fourth Medicinal Cannabis Oil Product  
 
28 Feb 2020    Appendix 4D and Half Yearly Report  
 
27 Feb 2020    German Purchase Agreement with Demecan  
 
26 Feb 2020    Becoming a substantial holder - Elixxer Ltd  
 
25 Feb 2020    Becoming a substantial holder - FS  
 
21 Feb 2020    Initial Director's Interest Notice - AC  
 
21 Feb 2020    Initial Director's Interest Notice - FS  
 
21 Feb 2020    Initial Director's Interest Notice - NF  
 
21 Feb 2020    Initial Director's Interest Notice - MLB  
 
19 Feb 2020    Binding Purchase Agreement with UK-Based Astral Health  
 
19 Feb 2020    Confirmation Statements  
 
19 Feb 2020    Top 20 Holders  
 
19 Feb 2020    Distribution Schedule  
 
19 Feb 2020    Securities Trading Policy  
 
19 Feb 2020    Corporate Governance Statement  
 
19 Feb 2020    Employee Incentive Plan Terms  
 
19 Feb 2020    Updated Pro-Forma Balance Sheet  
 
19 Feb 2020    Financial Statements - 30 June 2019  
 
19 Feb 2020    Financial Statements - 30 June 2018  
 
19 Feb 2020    Constitution  
 
19 Feb 2020    Supplementary Prospectus  
 
19 Feb 2020    Prospectus  
 
19 Feb 2020    Appendix 1A and Information Form and Checklist  
 
19 Feb 2020    ASX Notice - Admission to Official List